LexDanaLexDanabeta
Inventor

Ricardo Attar

Inventor
Lawrenceville, NJ, US

Overview

19→
Patents
2002–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes5%
C07DHeterocyclic compounds4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,954,284EGFR and c-Met fibronectin type III domain binding molecules202110,774,130Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins202010,662,235Cysteine engineered fibronectin type III domain binding molecules202010,562,968Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof202010,106,620Blocking CD38 using anti-CD38 F(ab')2 to protect NK cells201810,072,088Anti-BCMA antibodies and uses thereof20189,902,762'Multivalent fibronectin based scaffold domain proteins'20189,850,310CD123 binding agents and uses thereof20179,725,497'EGFR and C-Met fibronectin type III domain binding molecules'20179,695,228'EGFR and c-Met fibronectin type III domain binding molecules'20178,728,483'Multivalent fibronectin based scaffold domain proteins'20148,492,328'Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators'20138,221,765'Multivalent fibronectin based scaffold domain proteins'20127,655,688'Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function'20107,225,083'Crystallographic structure of the androgen receptor ligand binding domain'20077,199,227'Polynucleotides encoding human histone deacetylase HDAC9c'20076,960,474'Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator'20056,795,776'Crystallographic structure of the androgen receptor ligand binding domain'20046,479,237'Methods for detecting interaction among several proteins'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2020Patents assigned to BRISTOL MYERS SQUIBB CO (11)· patent assignee history
2002–2020Based in Lawrenceville, NJ, US· patent location history
2012–2014Patents assigned to ATTAR RICARDO (2)· patent assignee history
2012–2014Patents assigned to CAMPHAUSEN RAY (2)· patent assignee history
2017–2021Patents assigned to JANSSEN BIOTECH INC (5)· patent assignee history
2017–2020Patents assigned to JANSSEN PHARMACEUTICA NV (3)· patent assignee history
2017–2018Based in Spring House, PA, US· patent location history
2020–2021Based in Lawrence Township, NJ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO112002–2020
JANSSEN BIOTECH INC52017–2021
JANSSEN PHARMACEUTICA NV32017–2020
ATTAR RICARDOself22012–2014
CAMPHAUSEN RAY22012–2014
Locations
LocationPatentsSpan
Lawrenceville, New Jersey, US132002–2020
Spring House, Pennsylvania, US42017–2018
Lawrence Township, New Jersey, US22020–2021